Cite
APA Citation
Do, K. T., Chow, L. Q. M., Reckamp, K., Sanborn, R. E., Burris, H., Robert, F., Camidge, D. R., Steuer, C. E., Strickler, J. H., Weise, A., Specht, J. M., Gutierrez, M., Haughney, P., Hengel, S., Derleth, C. L., & Yap, T. A. (2021). first‐In‐Human, First‐In‐Class, Phase I Trial of the Fucosylation Inhibitor SGN‐2FF in Patients with Advanced Solid Tumors. Oncologist, 26, 925–e1918. http://access.bl.uk/ark:/81055/vdc_100145640011.0x000031